ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,411, issued on May 27, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).
"Anti-CD38 binding domains" was invented by Kathleen Ann Elias (San Francisco), Gregory Landes (San Bruno, Calif.), Shweta Singh (South San Francisco, Calif.), Wouter Korver (South San Francisco, Calif.), Andrew Walling Drake (South San Francisco, Calif.), Mary Haak-Frendscho (San Francisco), Vinay Bhaskar (San Francisco) and Erin Willert (Round Rock, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided in this disclosure are anti-CD38 binding domains, a composition comprising the anti-CD38 binding domains, nucleic acids encoding the anti-CD38 binding doma...